Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud Delwel

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
Blood|July 9, 2009
Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2CMaike Schwieger, Andrea Schüler, Martin Forster, et al.
Blood|February 15, 2008
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimatedSanne Lugthart, Ellen van Drunen, Yvette van Norden, et al.
Cell Reports|September 19, 2019
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter InteractionAnetta Ptasinska, Anna Pickin, Salam A Assi, et al.
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
Haematologica|October 8, 2008
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profilingRoel G W Verhaak, Bas J Wouters, Claudia A J Erpelinck, et al.
Nature Communications|April 10, 2026
Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeabilityJ Miguel Mata, Jingming Liu, Sean M McKenna, et al.
British Journal of Haematology|August 26, 2024
Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCsMomoko Nakamura, Kazuhisa Chonabayashi, Megumi Narita, et al.
Blood|May 21, 2011
Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markersVeronika Rockova, Saman Abbas, Bas J Wouters, et al.
The Journal of Biological Chemistry|July 13, 2004
Translational control of putative protooncogene Nm23-M2 by cytokines via phosphoinositide 3-kinase signalingMarieke Joosten, Montserrat Blázquez-Domingo, Fokke Lindeboom, et al.
BMC Bioinformatics|July 14, 2006
HeatMapper: powerful combined visualization of gene expression profile correlations, genotypes, phenotypes and sample characteristicsRoel G W Verhaak, Mathijs A Sanders, Maarten A Bijl, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Blood|July 9, 2009
Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2CMaike Schwieger, Andrea Schüler, Martin Forster, et al.
Blood|February 15, 2008
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimatedSanne Lugthart, Ellen van Drunen, Yvette van Norden, et al.
Cell Reports|September 19, 2019
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter InteractionAnetta Ptasinska, Anna Pickin, Salam A Assi, et al.
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
Haematologica|October 8, 2008
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profilingRoel G W Verhaak, Bas J Wouters, Claudia A J Erpelinck, et al.
Nature Communications|April 10, 2026
Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeabilityJ Miguel Mata, Jingming Liu, Sean M McKenna, et al.
British Journal of Haematology|August 26, 2024
Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCsMomoko Nakamura, Kazuhisa Chonabayashi, Megumi Narita, et al.
Blood|May 21, 2011
Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markersVeronika Rockova, Saman Abbas, Bas J Wouters, et al.
The Journal of Biological Chemistry|July 13, 2004
Translational control of putative protooncogene Nm23-M2 by cytokines via phosphoinositide 3-kinase signalingMarieke Joosten, Montserrat Blázquez-Domingo, Fokke Lindeboom, et al.
BMC Bioinformatics|July 14, 2006
HeatMapper: powerful combined visualization of gene expression profile correlations, genotypes, phenotypes and sample characteristicsRoel G W Verhaak, Mathijs A Sanders, Maarten A Bijl, et al.
Pageof 14